Analysis

Biotechnology firm Century Therapeutics has initiated a dramatic corporate restructuring, eliminating nearly half of its workforce and replacing key executives....

The biotechnology sector is bracing for a pivotal event as aTyr Pharma approaches the release of critical Phase 3 clinical...

After a prolonged period of significant challenges, TruBridge shares are displaying initial, albeit cautious, positive momentum. The stock closed its...

A prominent "Buy" recommendation from investment bank Clear Street has generated renewed optimism around Crescent Capital BDC. The firm's analyst...

The travel technology sector is experiencing significant turbulence, and Sabre Corporation finds itself at the center of the storm. The...

While numerous financial institutions continue to grapple with interest rate concerns, California-based Heritage Commerce Corp is demonstrating remarkable strength. This...

Financial markets are grappling with the implications of unexpectedly weak US employment data, creating a complex environment for regional banking...

The luxury goods sector continues to face headwinds, creating a split among market experts regarding LVMH's outlook. A dramatic upgrade...

While market uncertainty dominates many investor conversations, the iShares MSCI World ETF tells a compelling story of continued technology sector...

Viking Therapeutics shares encountered selling pressure as the market digested Phase II trial data for its oral obesity treatment candidate...